Coagulation factor VII gene haplotypes, obesity-related traits, and cardiovascular risk in young women

Journal of Thrombosis and Haemostasis

Volumn 5, Issue 1, 2007, Pages 42-49

  Reiner, Alex P ^a   Carlson, C S ^a   Rieder, M J ^a   Siscovick, D S ^a   Liu, K ^b   Chandler, W L ^a   Green, D ^b   Schwartz, S M ^a   Nickerson, D A ^a  

^a UNIVERSITY OF WASHINGTON   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

Author keywords

Factor VII; Haplotypes; Myocardial infarction; Obesity

Indexed keywords

BLOOD CLOTTING FACTOR 7; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; ORAL CONTRACEPTIVE AGENT;

ADULT; ALLELE; ARTERY THROMBOSIS; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CIGARETTE SMOKING; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; GENE EXPRESSION; GENE FREQUENCY; HAPLOTYPE; HEART INFARCTION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTOLIC BLOOD PRESSURE; UNITED STATES; WOMEN'S HEALTH;

ADOLESCENT; ADULT; BLOOD PRESSURE; BODY MASS INDEX; CARDIOVASCULAR DISEASES; CASE-CONTROL STUDIES; CHOLESTEROL, HDL; COHORT STUDIES; FACTOR VII; FEMALE; GENETIC PREDISPOSITION TO DISEASE; HAPLOTYPES; HUMANS; HYPERTENSION; LINEAR MODELS; MIDDLE AGED; MYOCARDIAL INFARCTION; OBESITY; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 33845543315     PISSN: 15387933     EISSN: 15387836     Source Type: Journal    
DOI: 10.1111/j.1538-7836.2006.02279.x     Document Type: Article

References (24)

1. Kudaravalli R, Tidd T, Pinotti M, Ratti A, Santacroce R, Margaglione M, Dallapiccola B, Bernardi F, Fortina P, Devoto M, Pollak E. Polymorphic changes in the 5′ flanking region of factor VII have a combined effect on promoter strength. Thromb Haemost 2002; 88: 763-7.
2. Humphries S, Temple A, Lane A, Green F, Cooper J, Miller G. Low plasma levels of factor VIIc and antigen are more strongly associated with the 10 base promoter (-323) insertion than the glutamine 353 variant. Thromb Haemost 1996; 75: 567-72.
3. Hunault M, Arbini AA, Lopaciuk S, Carew JA, Bauer KA. The Arg353Gln polymorphism reduces the level of coagulation factor VII: In vivo and in vitro studies. Arterioscler Thromb Vasc Biol 1997; 17: 2825-9.
4. Iacoviello L, Di Castelnuovo A, De Knijff P, D'Orazio A, Amore C, Arboretti R, Kluft C, Benedetta Donati M. Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction. N Engl J Med 1998; 338: 79-85.
5. Girelli D, Russo C, Ferraresi P, Olivieri O, Pinotti M, Friso S, Manzato F, Mazzucco A, Bernardi F, Corrocher R. Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease. N Engl J Med 2000; 343: 774-80.
6. Doggen DJM, Cats VM, Bertina RM, Reitsma PH, Vandenbroucke JP, Rosendaal FR. A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men. Thromb Haemost 1998; 80: 281-5.
7. Ardissino D, Mannucci PM, Merlini PA, Duca F, Fetiveau R, Tagliabue L, Tubaro M, Galvani M, Ottani F, Ferrario M, Corral J, Margaglione M. Prothrombotic genetic risk factors in young survivors of myocardial infarction. Blood 1999; 94: 46-51.
8. Nederhand RJ, de Maat MP, Jukema JW. Regression Growth Evaluation Statin Study group. Factor VII polymorphisms and myocardial infarction: What is special in Italians? REGRESS study group. Regression Growth Evaluation Statin Study. Thromb Haemost 2001; 85: 746-7.
9. Sass C, Blanquart C, Morange PE, Pfister M, Visvikis-Siest S. Association between factor VII polymorphisms and blood pressure: The Stanislas cohort. Hypertension 2004; 44: 674-80.
10. Carew JA, Basso F, Miller GJ, Hawe E, Jackson AA, Humphries SE, Bauer KA. A functional haplotype in the 5′ flanking region of the factor VII gene is associated with an increased risk of coronary heart disease. J Thromb Haemost 2003; 1: 2179-85.
11. Bozzini C, Girelli D, Bernardi F, Ferraresi P, Olivieri O, Pinotti M, Martinelli N, Manzato F, Friso S, Villa G, Pizzolo F, Beltrame F, Corrocher R. Influence of polymorphisms in the factor VII gene promoter on activated factor VII levels and on the risk of myocardial infarction in advanced coronary atherosclerosis. Thromb Haemost 2004; 92: 541-9.
12. Peyvandi F, Bernardinelli L, Martini CH, Celli P, Mannucci PM. Factor VII gene polymorphisms are not associated with myocardial infarction in young women. J Thromb Haemost 2005; 3: 803-4.
13. Carlson CS, Eberle MA, Rieder MJ, Yi Q, Kruglyak L, Nickerson DA. Selecting a maximally informative set of single-nucleotide polymorphisms for association analyses using linkage disequilibrium. Am J Hum Genet 2004; 74: 106-20.
14. Stephens M, Donnelly P. A comparison of Bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 2003; 73: 1162-9.
15. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S. Surveillance and ascertainment of cardiovascular events: The cardiovascular health study. Ann Epidemiol 1995; 5: 278-85.
16. Friedman GD, Cutter GR, Donahue RP, Hughes GH, Hulley SB, Jacobs Jr DR, Liu K, Savage PJ. CARDIA: Study design, recruitment, and some characteristics of the examined subjects. J Clin Epidemiol 1988; 41: 1105-16.
17. Green D, Chamberlain MA, Ruth KJ, Folsom AR, Liu K. Factor VII, cholesterol, and triglycerides. The CARDIA Study. Coronary Artery Risk Development in Young Adults Study. Arterioscler Thromb Vasc Biol 1997; 17: 51-5.
18. French B, Lumley T, Monks SA, Rice KM, Hindorff LA, Reiner AP, Psaty BM. Simple estimates of haplotype relative risks in case-control data. Genet Epidemiol 2006; 30: 485-94.
19. Stengard JH, Salomaa V, Rasi V, Vahtera E, Ehnholm C, Krusius T, Perola M, Vartiainen E. Utility of the Arg/Gln polymorphism of the factor VII (FVII) gene, serum lipid levels and body mass index in the prediction of the FGII:C and FVII:Ag in North Karelia; a cross-sectional and prospective study. Blood Coagul Fibrinolysis 2001; 12: 445-52.
20. Folsom AR, Wu KK, Rasmussen M, Chambless LE, Aleksic N, Nieto FJ. Determinants of population changes in fibrinogen and factor VII over 6 years: The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb Vasc Biol 2000; 20: 601-6.
21. Di Castelnuovo A, D'Orazio A, Amore C, Falanga A, Kluft C, Donati MB, Iacoviello L. Genetic modulation of coagulation factor VII plasma levels: Contribution of different polymorphisms and gender-related effects. Thromb Haemost 1998; 80: 592-7.
22. Eriksson-Berg M, Deguchi H, Hawe E, Scanavini D, Orth-Gomer K, Schenck-Gustafsson K, Humphries SE, Silveira A, Hamsten A. Influence of factor VII gene polymorphisms and environmental factors on plasma coagulation factor VII concentrations in middle-aged women with and without manifest coronary heart disease. Thromb Haemost 2005; 93: 351-8.
23. Di Bitondo R, Hall AJ, Peake IR, Iacoviello L, Winship PR. Oestrogenic repression of human coagulation factor VII expression mediated through an oestrogen response element sequence motif in the promoter region. Hum Mol Genet 2002; 11: 723-31.
24. Carew JA, Jackson AA, Bauer KA. ARP1 interacts with the 5′ flanking region of the coagulation factor VII gene. J Thromb Haemost 2003; 1: 1220-7.